NasdaqCM - Delayed Quote • USD
Edesa Biotech, Inc. (EDSA)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:59 PM EDT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-6,251.9160
-6,636.4830
-12,279.3020
-13,664.9320
-4,986.3400
Investing Cash Flow
--
--
-5.6560
-6.1460
19.0730
Financing Cash Flow
2,224.0780
4,830.1110
11,629.6280
14,174.7410
7,092.7490
End Cash Position
4,242.3690
5,361.3970
7,090.9190
7,839.2590
7,213.6950
Capital Expenditure
-34.3390
--
-5.6560
-6.1460
-34.3390
Issuance of Capital Stock
1,632.7220
4,345.0170
11,957.6870
12,662.3570
4,360.5000
Issuance of Debt
--
--
--
--
29.7480
Free Cash Flow
-6,251.9160
-6,636.4830
-12,284.9580
-13,671.0780
-5,020.6790
9/30/2020 - 6/21/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PSTV Plus Therapeutics, Inc.
1.6900
+1.81%
NLSP NLS Pharmaceutics Ltd.
0.1367
+3.25%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2376
-0.50%
INDP Indaptus Therapeutics, Inc.
2.1100
-3.21%
NNVC NanoViricides, Inc.
1.1000
-0.90%
FWBI First Wave BioPharma, Inc.
2.7400
+0.37%
SNTI Senti Biosciences, Inc.
0.2900
+4.05%
ATORX.ST Alligator Bioscience AB (publ)
0.9250
+1.09%
TSOI Therapeutic Solutions International, Inc.
0.0006
+9.09%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%